LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 74.21 | 21.74 | 8209 | 6235 | 1.3165 | 1.0685 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 74.21 | 21.74 | 1 | 6235 | 0.0002 | -0.3142 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 74.21 | 21.74 | 9324 | 6235 | 1.4953 | 1.1010 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 76.18 | 21.74 | 2062 | 6114 | 0.3372 | 0.7499 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 76.18 | 21.74 | 8403 | 6114 | 1.3743 | 1.0797 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 76.18 | 21.74 | 1 | 6114 | 0.0002 | -0.3151 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 76.18 | 21.74 | 9634 | 6114 | 1.5756 | 1.1150 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 78.15 | 21.74 | 2263 | 6167 | 0.3669 | 0.7684 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 78.15 | 21.74 | 8750 | 6167 | 1.4187 | 1.0877 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 78.15 | 21.74 | 1 | 6167 | 0.0002 | -0.3147 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 78.15 | 21.74 | 9909 | 6167 | 1.6066 | 1.1198 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 80.12 | 21.74 | 2258 | 6211 | 0.3635 | 0.7667 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 80.12 | 21.74 | 8933 | 6211 | 1.4381 | 1.0911 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 80.12 | 21.74 | 5 | 6211 | 0.0008 | -0.1649 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 80.12 | 21.74 | 10060 | 6211 | 1.6195 | 1.1217 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 82.09 | 21.74 | 2475 | 6201 | 0.3991 | 0.7870 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 82.09 | 21.74 | 9201 | 6201 | 1.4837 | 1.0991 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 82.09 | 21.74 | 4 | 6201 | 0.0006 | -0.1874 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 82.09 | 21.74 | 10329 | 6201 | 1.6656 | 1.1291 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 84.06 | 21.74 | 2168 | 6152 | 0.3524 | 0.7596 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 84.06 | 21.74 | 9267 | 6152 | 1.5063 | 1.1032 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 84.06 | 21.74 | 1 | 6152 | 0.0002 | -0.3148 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 84.06 | 21.74 | 10458 | 6152 | 1.6999 | 1.1346 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 86.03 | 21.74 | 2045 | 6155 | 0.3322 | 0.7469 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 86.03 | 21.74 | 9391 | 6155 | 1.5257 | 1.1065 | MN20160310_N01 | C22 |